Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tetanus, Diphtheria and Acellular Pertussis Vaccination”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Post-approval studies (Phase 4)Study completedNCT04535037
What this trial is testing

Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Who this might be right for
Diphtheria
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT00452686
What this trial is testing

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Who this might be right for
DiphtheriaAcellular PertussisTetanus
GlaxoSmithKline 660
Post-approval studies (Phase 4)Study completedNCT03530124
What this trial is testing

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Who this might be right for
ApneaApnea NeonatalPrematurity
Duke University 223
Post-approval studies (Phase 4)Looking for participantsNCT06135636
What this trial is testing

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Who this might be right for
Non-birthing Partner Vaccination in PregnancyTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationVaccine Exposure During Pregnancy
Women and Infants Hospital of Rhode Island 150
Post-approval studies (Phase 4)Study completedNCT00304265
What this trial is testing

Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

Who this might be right for
PertussisDiphtheriaTetanus+1 more
Sanofi Pasteur, a Sanofi Company 215
Post-approval studies (Phase 4)Ended earlyNCT03188458
What this trial is testing

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Who this might be right for
Diphtheria-Tetanus-Acellular Pertussis
GlaxoSmithKline 18
Large-scale testing (Phase 3)Study completedNCT01267058
What this trial is testing

Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

Who this might be right for
DiphtheriaPertussisTetanus
GlaxoSmithKline 550
Post-approval studies (Phase 4)Study completedNCT01711645
What this trial is testing

Tdap Vaccine in Post-Partum Women

Who this might be right for
DiphtheriaPertussisTetanus
National Institute of Allergy and Infectious Diseases (NIAID) 55
Post-approval studies (Phase 4)Study completedNCT00548171
What this trial is testing

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Who this might be right for
Acellular PertussisTetanusDiphtheria+1 more
GlaxoSmithKline 203
Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900
Post-approval studies (Phase 4)Study completedNCT01323959
What this trial is testing

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

Who this might be right for
Acellular PertussisPoliomyelitisDiphtheria+1 more
GlaxoSmithKline 212
Large-scale testing (Phase 3)Study completedNCT02858440
What this trial is testing

Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

Who this might be right for
DiphtheriaTetanusPertussis+2 more
GlaxoSmithKline 235
Post-approval studies (Phase 4)Study completedNCT01147900
What this trial is testing

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 180
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Testing effectiveness (Phase 2)Ended earlyNCT00871741
What this trial is testing

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Who this might be right for
TetanusPoliomyelitisNeisseria Meningitidis+4 more
GlaxoSmithKline 16
Post-approval studies (Phase 4)Study completedNCT01457547
What this trial is testing

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+3 more
GlaxoSmithKline 494
Large-scale testing (Phase 3)Study completedNCT00655148
What this trial is testing

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Who this might be right for
Active Immunization
Statens Serum Institut 817
Post-approval studies (Phase 4)Looking for participantsNCT07097012
What this trial is testing

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Who this might be right for
RSVTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationPregnancy+1 more
Canadian Immunization Research Network 60
Load More Results